>  
  >  
Report Detail

Sickle Cell Anemia Therapeutics – Pipeline Assessment and Market Forecasts to 2018

Publisher Name :
Date: 1-Nov-2012
No. of pages: 72

GlobalData, the industry analysis specialist, has released its new report, “Sickle Cell Anemia Therapeutics – Pipeline Assessment and Market Forecasts to 2018”. The report is an essential source of information and analysis on the global Sickle Cell Anemia Therapeutics market. The report identifies the key trends shaping and driving the global Sickle Cell Anemia Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Sickle Cell Anemia Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

The report provides information on the key drivers and challenges of the Sickle Cell Anemia Therapeutics market. Its scope includes -

  • Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Sickle Cell Anemia Therapeutics market revenues data from 2005 to 2009, forecast for eight years to 2018.
  • Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes.
  • Analysis of the current and future competition in the seven key countries Sickle Cell Anemia Therapeutics market.
  • Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
  • Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Sickle Cell Anemia Therapeutics market.
  • Analysis of key recent licensing and partnership agreements in Sickle Cell Anemia Therapeutics market

Reasons to buy

The report will enhance your decision making capability. It will allow you to -

  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving the global Sickle Cell Anemia Therapeutics market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Sickle Cell Anemia Therapeutics market in future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
  • What’s the next big thing in the global Sickle Cell Anemia Therapeutics market landscape? – Identify, understand and capitalize.

Sickle Cell Anemia Therapeutics – Pipeline Assessment and Market Forecasts to 2018

Table Of Contents

1 Table Of Contents

2 Executive Summary

3 Introduction
3.1 Overview
3.2 Epidemiology
3.3 Etiology
3.4 Symptoms
3.5 Diagnosis
3.6 Pathology
3.7 Treatment and Management Pattern
3.8 Referral Pathway

4 Market Characterization
4.1 Major Markets, Market Size (2005-2010)
4.2 Major Markets, Market Forecast (2010-2018)
4.3 US Market Size (2005-2010)
4.4 US Market Forecast (2010-2018)
4.5 France Market Size (2005-2010)
4.6 France Market Forecast (2010-2018)
4.7 Germany Market Size (2005-2010)
4.8 Germany Market Forecast (2010-2018)
4.9 Italy Market Size (2005-2010)
4.1 Italy Market Forecast (2010-2018)
4.11 Spain Market Size (2005-2010)
4.12 Spain Market Forecast (2010-2018)
4.13 UK Market Size (2005-2010)
4.14 UK Market Forecast (2010-2018)
4.15 Japan Market Size (2005-2010)
4.16 Japan Market Forecast (2010-2018)
4.17 Drivers and Barriers
4.18 Opportunity & Unmet Need Analysis
4.19 Key Takeaway

5 Competitive Assessment
5.1 Overview
5.1.1 Strategic Competitor Assessment
5.2 Marketed Product Profiles
5.2.1 Marketed Drug 1
5.2.1.1 Overview
5.2.1.2 Efficacy
5.2.1.3 Safety
5.2.1.4 Clinical Study Details
5.2.1.5 Annual Cost of Therapy
5.2.1.6 Historical Sales
5.3 Key Takeaway

6 Pipeline Assessment
6.1 Overview
6.2 Strategic Pipeline Assessment
6.3 Pipeline Analysis by Phase of Development
6.3.1 Phase III Clinical Pipeline
6.3.2 Phase II Clinical Pipeline
6.3.3 Phase I Clinical Pipeline
6.3.4 Pre-clinical & Discovery Phase
6.4 Pipeline by Mechanism of Action
6.5 Technology Trends Analytical Framework
6.6 Clinical Pipeline by Mechanism of Action, and by Monotherapy & Combination therapy
6.7 Most Promising Drugs under Clinical Development
6.8 Most Promising Drug Profiles
6.8.1 Pipeline Drug 1
6.81.1 Overview
6.8.1.2 Efficacy
6.8.1.3 Safety
6.8.1.4 Clinical Study Details
6.9 Key Takeaway

8 Clinical Trials Mapping
8.1 Clinical Trials by Region/Country
8.2 Clinical Trials by Phase
8.3 Clinical Trials by Trial Status
8.4 Prominent Sponsors
8.5 Top Ten Companies Participating in Therapeutics Clinical Trials

9 Strategic Assessment
9.1 Key Events Impacting the Future Market
9.2 Future Market Competition Scenario

10 Future Players
10.1 Introduction
10.2 Company Profiles
10.2.1 Profiling of top 10 companies among late stage pipeline including deal, alliance and partnerships
10.2.3 Tabular presentation details of other companies in the pipeline
10.3 Key Takeaway

11 Licensing & Partnership Deals

12 Appendix

  • Understand the Basics before Entering the World of IPTV
    IPTV or internet protocol television is an innovative technology, which has changed the appearance of the television programming across the globe. Internet protocol television provides television programming through broadband connection, which works according to the internet protocols. Television viewers who want to enjoy this viewing experience need to subscribe to the IPTV service and buy [...]
  • Introduction to Digital Radiography Imaging
    X-ray imaging is as a diagnostic method for quite some time now. Digital radiography is one of the common x-ray imaging techniques, which is popular in the medical discipline. In this technology, digital x-ray sensors are used that help capturing images onto the image capture devices. These devices then convert these images into digital image [...]
  • Computed Tomography (CT) Scan Technology Important For Therapeutic & Diagnostic
    Various medical disciplines use several types of tests and scans for therapeutic and diagnostic purposes. Computed tomography is one of the common medical imaging procedures. Also known as CT scan, this technology uses computed X-rays to produce tomographic images of various body parts. This nondestructive process helps visualizing various interior features of the body, within [...]
  • An Overview of Interactive Television with Benefits and Features
    Media convergence technology has reached to new heights. Interactive television or ITV is one of the popular forms of media convergence that adds data services to the conventional television sets. In simple language, interactive TV is the television that the users can interact with and change its appearance as per their own preferences. This feature [...]
  • What is Home Healthcare and How to Find Suitable Services ?
    Old age soon takes its toll on the abilities of taking care of your personal and healthcare needs. The number of senior citizens requiring assistance for healthcare is significantly rising. Not all of them are able to seek help from their loved ones. Elderly, who are not able to receive personal attention from their relatives [...]
  • Research and Development Prospect of China Dialysis Market, 2013-2017
    "......nd domestic key enterprise, and finally launches a forecast for this industry's future development, which can provide decision-making reference for the enterprises and investors. In 2012, the scale of China's dialysis market was about CNY 12 billi......"
  • Cancer Monoclonal Antibody Partnering Terms and Agreements
    "...... upfronts, milestones and royalties by stage of development Cancer monoclonal antibody partnering contract documents Top cancer monoclonal antibody deals by value The Cancer Monoclonal Antibody Partnering Agreements report provides an understa......"
  • OpportunityAnalyzer: Idiopathic Pulmonary Fibrosis (IPF) – Opportunity Analysis and Forecasts to 2017
    "......, the IPF treatment landscape is set to dramatically change with the anticipated approval and subsequent launch of two small molecule therapeutic options in 2015; InterMune's Esbriet in the US and Boehringer Ingelheim's Nintedanib globally. There is ......"
  • OpportunityAnalyzer: Cystic Fibrosis Therapeutics – Opportunity Analysis and Forecasts to 2017
    "...... have a limited number of available treatment options and significant unmet needs still exist. Opportunities are significant for new therapies that will improve symptoms, change the course of this disease, as well as increase therapy options. The int......"
  • Indolent Lymphoma – Pipeline Review, H1 2013
    "......st updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Indolent Lymphoma. Indolent Lymphoma - Pipeline Review, Half Year is built using data and information so......"